Clinical Trial Update: Argatroban Versus Lepirudin in Critically Ill Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing Argatroban to Lepirudin in critically ill patients with heparin-induced thrombocytopenia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heparin-induced Thrombocytopenia

Drugs mentioned

• Argatroban (argatroban)
• Lepirudin (lepirudin)

Snippet

Sponsor: Heinrich-Heine University, Duesseldorf | Conditions: Heparin Induced Thrombocytopenia (HIT) | Phase 4 | Status: TERMINATED